[1]
Chaiyarat, P., Manachevakul, S. and Phopongsin, S. 2026. Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comparison of Erlotinib and Osimertinib within the Thai Healthcare System. Journal of Health Policy, Law and Administration . 12, 2 (Apr. 2026), 383–394.